390 related articles for article (PubMed ID: 25909991)
1. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice.
Liu Y; Yan C; Wang Y; Nakagawa Y; Nerio N; Anghel A; Lutfy K; Friedman TC
Endocrinology; 2006 Nov; 147(11):5061-8. PubMed ID: 16873540
[TBL] [Abstract][Full Text] [Related]
4. PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways.
Cang X; Wang X; Liu P; Wu X; Yan J; Chen J; Wu G; Jin Y; Xu F; Su J; Wan C; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(1):431-438. PubMed ID: 27423393
[TBL] [Abstract][Full Text] [Related]
5. Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation.
Baranowski M; Zabielski P; Błachnio-Zabielska AU; Harasim E; Chabowski A; Górski J
Cell Physiol Biochem; 2014; 33(4):1047-57. PubMed ID: 24732673
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
7. Anti-Metabolic Syndrome Effects of Fucoidan from
Wang X; Shan X; Dun Y; Cai C; Hao J; Li G; Cui K; Yu G
Molecules; 2019 Sep; 24(18):. PubMed ID: 31547311
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity.
Mo J; Zhou Y; Yang R; Zhang P; He B; Yang J; Li S; Shen Z; Chen P
Pharmacol Rep; 2019 Dec; 71(6):1160-1167. PubMed ID: 31675670
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation.
Lee CS; Park M; Han J; Lee JH; Bae IH; Choi H; Son ED; Park YH; Lim KM
J Invest Dermatol; 2013 Apr; 133(4):1063-71. PubMed ID: 23223141
[TBL] [Abstract][Full Text] [Related]
10. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
11. CtBP2 ameliorates palmitate-induced insulin resistance in HepG2 cells through ROS mediated JNK pathway.
Liu P; Shi L; Cang X; Huang J; Wu X; Yan J; Chen L; Cui S; Ye X
Gen Comp Endocrinol; 2017 Jun; 247():66-73. PubMed ID: 28111233
[TBL] [Abstract][Full Text] [Related]
12. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.
Cao G; Liang Y; Broderick CL; Oldham BA; Beyer TP; Schmidt RJ; Zhang Y; Stayrook KR; Suen C; Otto KA; Miller AR; Dai J; Foxworthy P; Gao H; Ryan TP; Jiang XC; Burris TP; Eacho PI; Etgen GJ
J Biol Chem; 2003 Jan; 278(2):1131-6. PubMed ID: 12414791
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor agonist alleviated high glucose-induced endothelial progenitor cell dysfunction via inhibition of reactive oxygen species and activation of AMP-activated protein kinase.
Li X; Song Y; Han Y; Wang D; Zhu Y
Microcirculation; 2012 Aug; 19(6):547-53. PubMed ID: 22507035
[TBL] [Abstract][Full Text] [Related]
15. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
[TBL] [Abstract][Full Text] [Related]
16. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.
Laffitte BA; Chao LC; Li J; Walczak R; Hummasti S; Joseph SB; Castrillo A; Wilpitz DC; Mangelsdorf DJ; Collins JL; Saez E; Tontonoz P
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5419-24. PubMed ID: 12697904
[TBL] [Abstract][Full Text] [Related]
17. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
[TBL] [Abstract][Full Text] [Related]
18. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
19. Mulberry anthocyanin extract ameliorates insulin resistance by regulating PI3K/AKT pathway in HepG2 cells and db/db mice.
Yan F; Dai G; Zheng X
J Nutr Biochem; 2016 Oct; 36():68-80. PubMed ID: 27580020
[TBL] [Abstract][Full Text] [Related]
20. Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance.
Kumashiro N; Tamura Y; Uchida T; Ogihara T; Fujitani Y; Hirose T; Mochizuki H; Kawamori R; Watada H
Diabetes; 2008 Aug; 57(8):2083-91. PubMed ID: 18487450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
